Feasibility of online risk-based monitoring by patients: the Natalizumab case

Author(s):
Noort, E.M.J. van; Kasteleyn, M.J.; Jongen, P.J.H.; Veen, H.C.C.M.I.; Chavannes, N.H. (0000-0002-8607-9199); MSmonitor Study Grp
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-10-31
Language
English
Is part of
Multiple Sclerosis Journal (2017), Vol. 23, p. 925-926
hdl
1887/115851